PATENT CLAIM ANALYSIS

Application Number: 16025296
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["424", "186100"]

Abstract:
The invention relates to neutralizing antibodies, and antibody fragments thereof, having high potency in neutralizing hCMV, wherein said antibodies and antibody fragments are specific for one, or a combination of two or more, hCMV gene UL products. The invention also relates to immortalized B cells that produce, and to epitopes that bind to, such antibodies and antibody fragments. In addition, the invention relates to the use of the antibodies, antibody fragments, and epitopes in screening methods as well as in the diagnosis, prevention, and therapy of disease.

Claim (Index 72):
A nucleic acid molecule comprising a nucleotide sequence that is at least 95% identical to any one of SEQ ID NOs: 322-327 and 333.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 95.0
- Lexical Diversity: 1.92453
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15358868', '15637513', '15358845', '15716818', '12503822']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7545571504160609
- 35 USC 102 Novelty (BERT): 0.5528558484600637
- Combined Prediction Score: 0.7343870202204612
- Mean Citation Score: 457.548334
- Max Citation Score: 458.3289
- Similarity Product: 264.5303649435997

Labels:
- Claim Label 101: 0
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test